There are possibilities like structure based engineering of monoclonal antibody for improving solubility. Can we use these kind of engineering tools to improve specificity and sensitivity of a mAb, especially in case of rec mAb? Your valuable suggestions and comments are highly appreciated.

Similar questions and discussions